Measuring response in solid tumors: unidimensional versus bidimensional measurement - PubMed (original) (raw)
Meta-Analysis
. 1999 Mar 17;91(6):523-8.
doi: 10.1093/jnci/91.6.523.
Affiliations
- PMID: 10088622
- DOI: 10.1093/jnci/91.6.523
Meta-Analysis
Measuring response in solid tumors: unidimensional versus bidimensional measurement
K James et al. J Natl Cancer Inst. 1999.
Abstract
Background: Tumor shrinkage is a common end point used in screening new cytotoxic agents. The standard World Health Organization criterion for partial response is a 50% or more decrease in the sum of the products of two measurements (the maximum diameter of a tumor and the largest diameter perpendicular to this maximum diameter) of individual tumors. However, theoretically, the simple sum of the maximum diameters of individual tumors is more linearly related to cell kill than is the sum of the bidimensional products. It has been hypothesized that the calculation of bidimensional products is unnecessary, and a 30% decrease in the sum of maximum diameters of individual tumors (assuming spherical shape and equivalence to a 50% reduction in the sum of the bidimensional products) was proposed as a new criterion. We have applied the standard response and the new response criteria to the same data to determine whether the same number of responses in the same patients would result.
Methods: Data from 569 patients included in eight studies of a variety of cancers were reanalyzed. The two response criteria were separately applied, and the results were compared using the kappa statistic. The importance of confirmatory measurements and the frequency of nonspherical tumors were also examined. In addition, for a subset of 128 patients, a unidimensional criterion for disease progression (30% increase in the sum of maximum diameters) was applied and compared with the standard definition of a 25% increase in the sum of the bidimensional products.
Results: Agreement between the unidimensional and bidimensional criteria was generally found to be good. The kappa statistic for concordance for overall response was 0.95.
Conclusion: We conclude that one dimensional measurement of tumor maximum diameter may be sufficient to assess change in solid tumors.
Comment in
- Measure once or twice -- does it really matter?
Hilsenbeck SG, Von Hoff DD. Hilsenbeck SG, et al. J Natl Cancer Inst. 1999 Mar 17;91(6):494-5. doi: 10.1093/jnci/91.6.494. J Natl Cancer Inst. 1999. PMID: 10088614 No abstract available. - Re: Measure once or twice--does it really matter?
James K, Eisenhauer E, Therasse P. James K, et al. J Natl Cancer Inst. 1999 Oct 20;91(20):1780-1. doi: 10.1093/jnci/91.20.1780. J Natl Cancer Inst. 1999. PMID: 10528032 No abstract available.
Similar articles
- Measuring response in solid tumors: comparison of RECIST and WHO response criteria.
Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Lee KS, Park K. Park JO, et al. Jpn J Clin Oncol. 2003 Oct;33(10):533-7. doi: 10.1093/jjco/hyg093. Jpn J Clin Oncol. 2003. PMID: 14623923 - CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.
Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. Prasad SR, et al. Radiology. 2002 Nov;225(2):416-9. doi: 10.1148/radiol.2252011604. Radiology. 2002. PMID: 12409574 Clinical Trial. - Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements.
Nishino M, Giobbie-Hurder A, Gargano M, Suda M, Ramaiya NH, Hodi FS. Nishino M, et al. Clin Cancer Res. 2013 Jul 15;19(14):3936-43. doi: 10.1158/1078-0432.CCR-13-0895. Epub 2013 Jun 6. Clin Cancer Res. 2013. PMID: 23743568 Free PMC article. - [New guidelines to evaluate the response to treatment "RECIST"].
Sasaki T. Sasaki T. Gan To Kagaku Ryoho. 2000 Dec;27(14):2179-84. Gan To Kagaku Ryoho. 2000. PMID: 11142160 Review. Japanese. - Tumor response evaluation in oncology: current update.
Shanbhogue AK, Karnad AB, Prasad SR. Shanbhogue AK, et al. J Comput Assist Tomogr. 2010 Jul;34(4):479-84. doi: 10.1097/RCT.0b013e3181db2670. J Comput Assist Tomogr. 2010. PMID: 20657213 Review.
Cited by
- How difficult is the validation of clinical biomarkers?
Voskuil J. Voskuil J. F1000Res. 2015 Apr 28;4:101. doi: 10.12688/f1000research.6395.1. eCollection 2015. F1000Res. 2015. PMID: 26069732 Free PMC article. - A European Society of Oncologic Imaging (ESOI) survey on the radiological assessment of response to oncologic treatments in clinical practice.
Cappello G, Romano V, Neri E, Fournier L, D'Anastasi M, Laghi A, Zamboni GA, Beets-Tan RGH, Schlemmer HP, Regge D. Cappello G, et al. Insights Imaging. 2023 Dec 20;14(1):220. doi: 10.1186/s13244-023-01568-6. Insights Imaging. 2023. PMID: 38117394 Free PMC article. - Improved survival with ipilimumab in patients with metastatic melanoma.
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ. Hodi FS, et al. N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525992 Free PMC article. Clinical Trial. - Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
Garg T, Shrigiriwar A, Habibollahi P, Cristescu M, Liddell RP, Chapiro J, Inglis P, Camacho JC, Nezami N. Garg T, et al. Cancers (Basel). 2022 Jul 10;14(14):3351. doi: 10.3390/cancers14143351. Cancers (Basel). 2022. PMID: 35884412 Free PMC article. Review. - Size assessment of breast lesions by means of a computer-aided detection (CAD) system for magnetic resonance mammography.
Levrini G, Sghedoni R, Mori C, Botti A, Vacondio R, Nitrosi A, Iori M, Nicoli F. Levrini G, et al. Radiol Med. 2011 Oct;116(7):1039-49. doi: 10.1007/s11547-011-0664-y. Epub 2011 Mar 19. Radiol Med. 2011. PMID: 21424564 English, Italian.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources